In August, the Good Clinical Trials Collaborative and four major clinical trials networks – ADVANcing Clinical Evidence in infectious Diseases, Africa Health Research Institute, Oxford University Clinical Research Unit, and The Global Health Network – unveiled a strategic collaboration aimed at bolstering clinical trials research in low- and middle-income countries (LMICs).

Under the Good Trials Prism program, the collaboration will drive the implementation of the principles of good randomized clinical trials in LMICs. Our goal is to enable collaborative, informative and efficient research responses to address critical public health challenges in these settings.

In a new article featured in Clinical Leader, Nick Medhurst, the Collaborative’s Team Lead, sheds light on the significance of advancing high-quality trials globally and in LMICs. He also delves into how Good Trials Prism can play a pivotal role in fostering knowledge and collaboration to drive impactful changes in clinical research.

Dive into the article here